LUKANG PHARMACEUTICAL

STRIVING TO DEVELOP FOR 50 YEARS CARING FOR HUMAN HEALTH
R&D INNOVATION
R&D RESULTS
Lukang Pharmaceutical as a state-level and high-tech enterprise, Vigorously implement technology strategy in new product reseach and technological progress, Adhere to the technical cooperation with independed reseach combined and scientific reseach and product structure adjustment combined, increase investment in reseach for new product and technological innovation.


In recent years, R&D centre has undertaken one national major science and technology project, one the national “863”plan, two the national torch plan projects, one the national key new product project, more than twenty the provincial science and technology plans, and passed the national acceptance and technology achievement and identification of new product, reached the leading domestic or the international advance level.

Multi-projects have reach the domestic advance level. “12th five-years”period, total gain twenty-five licenses of drug approval, get four new drug certificates and two clinical licenses and accepting more than thirty licenses of new drug and twenty-nine products in the assess, Win four Jining Science and Technology awards, Declare and accept twenty-four invention patents and authorized four patents and ten design patents, Again win “China patent Shandong star enterprise” title by Shandong provincial Science and Technology Department and Shandong Provincial Intellectual Property Office jointly, For the subsequent development of the company to provide a steady motive. 




In recent years, Shelile R&D centre has made one provincial technology achievement project, two provincial new product and technology projects, one municipal technology achievement project, five district technology achievement projects, two municipal technology progress awards, five district technology progress awards, two technology invention awards, There are sixteen enterprise standards of relevant feed additive and premixed feed to record in the provincial technical quality supervision bureau, there are twenty-three enterprise standards of non pharmaceutical aquatic drug to record in the municipal technical quality supervision bureau.

Shelile R&D centre pay more attention to protect Intellectual Property, which propect technology achievement by the form of patent, total get four invention patents and eight utility model patents and one appearance design patents, gain two certificates of three kinds new veterinary drug. There are three invention patents and two utility model patents and two certificates of two kinds new veterinary and two certificates of three kinds new veterinary and one certificate of four kinds new veterinary are being declared.




The bio-pesticide company has launched and registrated three new products of bacillus subtilis and 10%polyoxin soluble granules and 50000iu/mg bacillus thuringiensis soluble powder in 2015, field trials of this product is being carried out in Shandong, Hubei, Hunan, Sichuan and other places.

With the operation of the joint venture company, the joint venture product Hebernem has been tested and verified in the field of Shandong Agricultural Universty, is currently carring out registration in the domestic.